This Sunday the Chinese Health ministry announced that it found no clinical evidence that the milk powder, accused for causing apparent breast development in three infant girls in south-central China, has any link with it.
The ministry also revealed that it conducted tests on 73 samples of infant formula and there was no sign of any inappropriate hormones. These tests were done after the Chinese media had speculated that such hormones might be responsible for the infants' development.
The Chinese medical specialists said that the infants' physiological development was not unheard of, quoted the official Xinhua news agency.
Following the speculation in the Chinese media about the infant's health, without the benefit of scientific analysis, the free-wheeling nature of Chinese media has been underlined on health and business issues.
A leading Chinese milk powder company, Synutra, was at the center of the whole suspicion regarding the three infant girls' case, which were fed milk prepared from its powder.
The health ministry's report confirmed that out of the 73 samples, 42 were from Synutra and it had tested them without finding any unusual levels of hormones. One sample of a milk powder residue was from one of the infant girls' homes.
Related News
- Synutra to Open its Milk-Powder Plant for Public Inspection
- Share prices of Synutra rise after clearance from Health Ministry
- Kiwi key in developing milk standard
- Tainted Milk Causes Kidney Problems, Says Study
- Chinese Researchers on Their Way to Develop Alternative Human Breast Milk
- Fonterra plans further investment in China
- Worry over dairy sale
